BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 30 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $0 | -100.0% | 56 | -94.7% | 0.00% | – |
Q3 2018 | $1,000 | -50.0% | 1,056 | +5.6% | 0.00% | – |
Q2 2018 | $2,000 | -98.6% | 1,000 | -98.6% | 0.00% | – |
Q1 2018 | $147,000 | -24.2% | 70,866 | -5.9% | 0.00% | – |
Q4 2017 | $194,000 | – | 75,271 | +1505320.0% | 0.00% | – |
Q3 2017 | $0 | – | 5 | -97.2% | 0.00% | – |
Q4 2016 | $0 | – | 181 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 181 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 181 | +18000.0% | 0.00% | – |
Q1 2016 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLINSKY STEVEN B | 4,859,885 | $44,614,000 | 20.33% |
Senator Investment Group LP | 448,679 | $4,119,000 | 0.04% |
HIGHLAND CAPITAL MANAGEMENT LP | 162,177 | $1,489,000 | 0.03% |
Baker Brothers Advisors | 350,000 | $3,213,000 | 0.03% |
Alyeska Investment Group, L.P. | 94,131 | $864,000 | 0.01% |
SABBY MANAGEMENT, LLC | 30,000 | $275,000 | 0.01% |
FMR LLC | 1,302,070 | $11,953,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 15,427 | $142,000 | 0.00% |
BlackRock Investment Management, LLC | 846 | $8,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 17,290 | $159,000 | 0.00% |